Skip Ribbon Commands
Skip to main content
Menu

Dr Manju Chandran

Dr Manju Chandran

​MD, FACP, FACE, FAMS, CCD

Senior Consultant

Specialty: Endocrinology

Sub-specialties: Bone Metabolism

Conditions Treated by this Doctor:
Diabetes Mellitus, Disorders of Bone Metabolism, General Endocrinology, Hyperthyroidism, Hypothyroidism, Osteoporosis, Thyroid nodules, Thyroid Nodules.

Clinical Appointments

  • Senior Consultant Endocrinology Singapore General HospitalSingapore General Hospital

Profile

​Senior Consultant and Director of the Osteoporosis and Bone Metabolism Unit which she set up in 2008. 

Education

​Fellowship in Endocrinology and Metabolism from University of California San Diego School of Medicine, USA

Professional Appointments and Committee Memberships

  • Chairperson, Chapter of Endocrinologists, College of Physicians, Academy of Medicine Singapore, Elected Council Member, Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF), Past President, Endocrine and Metabolic Society of Singapore (EMSS), Treasurer, Osteoporosis Society Singapore 

Awards

  • International Osteoporosis Foundation CNS (Committee of National Societies) Medal of Excellence 2015
  • Gold Star Award Winner for the SGH OPTIMAL Program in the Global Map of Best Practice of the Capture the Fracture Campaign of the International Osteoporosis Foundation 2015
  • International Osteoporosis Foundation- World Congress on Osteoporosis International Young Investigator Award 2013
  • Service with a Heart Award 2010

Research Interests

  • ​Epidemiology and Health Economics of Osteoporosis
  • Rare Bone Disorders
  • Secondary Osteoporosis
  • Metabolic Bone Disorders
  • Diabetes and Osteoporosis
  • Artificial Intelligence in Osteoporosis

Publications

Selected out of 60+ publications
1. Fracture Risk Assessment in Clinical Practice: Why Do It? What to Do It With? Chandran M.J Clin Densitom. 2017 Jul - Sep;20(3):274-279
2. Diabetes Drug Effects on the Skeleton.Chandran M. Calcif Tissue Int. 2017 Feb;100(2):133-149. 
3. Mechanisms of diabetes mellitus-induced bone fragility. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL; IOF Bone and Diabetes Working Group.Nat Rev Endocrinol. 2017 Apr;13(4):208-219
4. A Retrospective Review of Imaging and Operative Modalities Performed in Patients with Primary Hyperparathyroidism at a Mid-Volume Surgical Centre in Southeast Asia.Tan MZ, Ng JC, Eisman JA, Ng DC, Hansen L, Chandran M. Ann Acad Med Singapore. 2016 May;45(5):191-7.
5. Surgery or no surgery: What works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population.Tay YK, Khoo  J, Chandran M. Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):55-61
6. AXIAL BMD IN DIABETIC AND NONDIABETIC SOUTHEAST ASIANS WITH HIP FRACTURES: DO RACE AND BODY MASS INDEX MATTER? Chandran M, Tay D, Tan M, Hao Y, Huang XF, Khoo J, Puar TH. Endocr Pract. 2016 Jun;22(6):716-25

Lead Investigator in the Evolution of Trabecular Bone Score following Renal Transplantation funded by the Lee Foundation Singhealth Transplant Grant
Principal Investigator from Singapore General Hospital for the Asia Latin America Fracture Observation Study 

Research Trials